Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. (Q53289054)

13 May 2018

title

Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. (English)

1 reference

13 May 2018

1 reference

William Jeffery Sandborn

series ordinal

object named as

William J Sandborn

1 reference

13 May 2018

Edward V Loftus

1 reference

13 May 2018

Alan R Zinsmeister

1 reference

13 May 2018

William Scott Harmsen

series ordinal

object named as

W Scott Harmsen

1 reference

13 May 2018

author name string

John B Kisiel

series ordinal

1 reference

13 May 2018

publication date

17 March 2011

1 reference

13 May 2018

Inflammatory Bowel Diseases

published in

1 reference

13 May 2018

volume

1 reference

13 May 2018

issue

1 reference

13 May 2018

page(s)

226-235

1 reference

13 May 2018

Ulcerative colitis and colorectal cancer. A population-based study

cites work

1 reference

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study

21 January 2018

1 reference

Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease

21 January 2018

1 reference

Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis

21 January 2018

1 reference

Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment

21 January 2018

1 reference

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies

21 January 2018

1 reference

Colorectal cancer prevention in ulcerative colitis: a case-control study.

21 January 2018

1 reference

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

21 January 2018

1 reference

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

21 January 2018

1 reference

Diagnosis and management of dysplasia in patients with inflammatory bowel diseases

21 January 2018

1 reference

Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study

21 January 2018

1 reference

5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis

21 January 2018

1 reference

Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.

21 January 2018

1 reference

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease

21 January 2018

1 reference

c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis

21 January 2018

1 reference

Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis

21 January 2018

1 reference

Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma

21 January 2018

1 reference

Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia

21 January 2018

1 reference

Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.

21 January 2018

1 reference

Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.21687

1 reference

13 May 2018

1 reference

13 May 2018